Condition
Gout Attack
Total Trials
6
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
50.0%
3 terminated out of 6 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
2 of 0 completed with results
Key Signals
2 with results0
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
P 2 (2)
P 3 (1)
P 4 (1)
Trial Status
Terminated3
Recruiting2
Unknown1
Clinical Trials (6)
Showing 6 of 6 trials
NCT05658575Phase 2Recruiting
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
NCT06863701Phase 3Recruiting
Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
NCT03621215Not ApplicableTerminated
The Effect of Tart Cherry Juice on Risk of Gout Attacks
NCT03636373Phase 4TerminatedPrimary
Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
NCT04067492Phase 2TerminatedPrimary
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
NCT04306653Not ApplicableUnknownPrimary
ACTH vs Betamethasone in Hospitalized Patients With Acute Gout
Showing all 6 trials